VRPX קפיטליזציה חשבונאית Virpax Pharmaceuticals Inc.

Virpax Pharmaceuticals (VRPX) ensures the secure transport of strictly controlled non-opioid analgesics, utilizing a warehouse network to protect margins and supply stability. The share price retrospective, recorded at -0.00, complements data on the development of nasal films and sprays designed for rapid brain action without addiction. Thanks to an autonomous product cycle, Virpax Pharmaceuticals (VRPX) ignores macroeconomic trends, remaining a reliable defensive asset.

This metric reflects the difference between all assets and liabilities, forming the equity base that directly depends on operational management efficiency. The current value of -0.00 demonstrates the real value of resources Virpax Pharmaceuticals (VRPX) invests in developing non-opioid analgesic delivery systems, while the trend in the book value of net assets allows investors to assess the financial stability of the biotech startup between reporting periods.